1-8 of 8
Michael J. Ehrhardt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FTY720 Promotes Engraftment of Allogeneic Donor Bone Marrow Stem Cells but Impairs Thymopoiesis Resulting in Delayed Graft Rejection.

Patricia A Taylor, DVM, Ryan M Kelly, PhD, Michael J Ehrhardt, Bruce R. Blazar, MD
Journal: Blood
Blood (2009) 114 (22): 3530.
https://doi.org/10.1182/blood.V114.22.3530.3530
Published: 2009
Journal Articles

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

Patricia A. Taylor, Michael J. Ehrhardt, Christopher J. Lees, Angela Panoskaltsis-Mortari, Arthur M. Krieg, Arlene H. Sharpe, William J. Murphy, Jonathan S. Serody, Hiroaki Hemmi, Shizuo Akira, Robert B. Levy, Bruce R. Blazar
Journal: Blood
Blood (2008) 112 (8): 3508–3516.
https://doi.org/10.1182/blood-2007-09-113670
Published: 2008
Journal Articles

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)

Patricia A. Taylor, Michael J. Ehrhardt, Christopher J. Lees, Jakub Tolar, Brenda J. Weigel, Angela Panoskaltsis-Mortari, Jonathan S. Serody, Volker Brinkmann, Bruce R. Blazar
Journal: Blood
Blood (2007) 110 (9): 3480–3488.
https://doi.org/10.1182/blood-2007-05-087940
Published: 2007
Journal Articles

Mechanisms Responsible for and Strategies To Overcome Bone Marrow (BM) Rejection in Allosensitized Recipients.

Patricia A. Taylor, Michael J. Ehrhardt, Matthew M. Roforth, Jessica M. Swedin, Angela Panoskaltsis-Mortari, Jonathan S. Serody, Bruce R. Blazar
Journal: Blood
Blood (2006) 108 (11): 3212.
https://doi.org/10.1182/blood.V108.11.3212.3212
Published: 2006
Journal Articles

Amelioration of Idiopathic Pneumonia Syndrome (IPS) and GVHD by KGF-Pretreatment Is Partly Mediated Via a STAT-6-Dependent Pathway in the Host.

Angela Panoskaltsis-Mortari, Andrew Price, Kevin Tram, Rita McFadden, Michael J. Ehrhardt, Michael J. Grusby, Bruce R. Blazar
Journal: Blood
Blood (2006) 108 (11): 3189.
https://doi.org/10.1182/blood.V108.11.3189.3189
Published: 2006
Journal Articles

FTY720 Inhibits Graft-Versus-Host Disease (GVHD) and Allogeneic Bone Marrow (BM) Graft Rejection Independent of Effects on T Cell Egress from Lymphoid Tissue.

Patricia A. Taylor, Michael J. Ehrhardt, Angela Panoskaltsis-Mortari, Jonathan S. Serody, Volker Brinkmann, Bruce R. Blazar
Journal: Blood
Blood (2006) 108 (11): 450.
https://doi.org/10.1182/blood.V108.11.450.450
Published: 2006
Journal Articles

Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients

Patricia A. Taylor, Michael J. Ehrhardt, Matthew M. Roforth, Jessica M. Swedin, Angela Panoskaltsis-Mortari, Jonathan S. Serody, Bruce R. Blazar
Journal: Blood
Blood (2006) 109 (3): 1307–1315.
https://doi.org/10.1182/blood-2006-05-022772
Published: 2006
Includes: Supplemental data
Journal Articles

Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions

Patricia A. Taylor, Christopher J. Lees, Jessica M. Wilson, Michael J. Ehrhardt, Matthew T. Campbell, Randolph J. Noelle, Bruce R. Blazar
Journal: Blood
Blood (2002) 100 (9): 3400–3407.
https://doi.org/10.1182/blood-2002-03-0872
Published: 2002